Sfoglia per AUTORE
BRESCIA MORRA V
Collezione AOU San Luigi di Orbassano

  

Items : 24

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study. in Journal of neurology / J Neurol. 2024 Jan;271(1):340-354. doi: 10.1007/s00415-023-11955-0. Epub 2023 Sep 16.
2024
AOU San Luigi di Orbassano

Zanetta C; Perini D; Brescia Morra V; Cordioli C; Granella F; Malucchi S; Totaro R; Valente MR; Conte A; Grimaldi L; Filippi M; Santoni L;

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2024 Aug;11(8):2008-2015. doi: 10.1002/acn3.52118. Epub 2024 Jul 5.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Brescia Morra V; Cocco E; Torri Clerici V; Spitaleri D; Clerici R; Vianello M; Quatrale R; Di Sapio A; Montepietra S; Gallo A; Bellantonio P; Gallo P; De Luca G; Cavalla P; Romano S; Granella F; Patti F; Foschi M; Inglese M; Portaccio E; Paolicelli D; Guerra T; Lucisano G; Iaffaldano P; Marfia GA; Boccia VD; Filippi M; Amato MP; Trojano M; et alii...

Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Oct;78:104907. doi: 10.1016/j.msard.2023.104907. Epub 2023 Jul 26.
2023
AOU San Luigi di Orbassano

Petracca M; Carotenuto A; Scandurra C; Moccia M; Rosa L; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Cellerino M; Bucello S; Ferraro E; Mattioli M; Chiodi A; Inglese M; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Lanzillo R; et alii...

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. in Journal of neurology / J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5.
2023
AOU San Luigi di Orbassano

Amato MP; Bergamaschi R; Centonze D; Mirabella M; Marfia GA; Totaro R; Lus G; Brescia Morra V; Aguglia U; Comi C; Cavalla P; Zaffaroni M; Rovaris M; Grimaldi LM; Leoni S; Malucchi S; Baldi E; Romano M; Falcini M; Perini P; Assetta M; Portaccio E; Sommacal S; Olivieri N; Parodi F; Todaro DS; Grassivaro N; Farina A; Mondino MM; et alii...

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression. in Journal of clinical medicine / J Clin Med. 2023 Mar 13;12(6):2215. doi: 10.3390/jcm12062215.
2023
AOU San Luigi di Orbassano

Scandurra C; Rosa L; Carotenuto A; Moccia M; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Ferraro E; Mattioli M; Chiodi A; Maldonato NM; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Petracca M; Lanzillo R;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. in Journal of neurology / J Neurol. 2022 Mar;269(3):1463-1469. doi: 10.1007/s00415-021-10708-1. Epub 2021 Jul 22.
2022
AOU San Luigi di Orbassano

Vitetta F; Pisano E; Malucchi S; Cavalla P; Cellerino M; Patti F; Lus G; Mirabella M; Zaffaroni M; Brescia Morra V; Capobianco M; Inglese M; Guerra T; Iaffaldano P; Ferraro D; Paolicelli D; Sola P; Trojano M;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 20
2022
AOU San Luigi di Orbassano

Sormani MP; Schiavetti I; Carmisciano L; Cordioli C; Filippi M; Radaelli M; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Cocco E; Scandellari C; Cavalla P; Pesci I; Zito A; Confalonieri P; Marfia GA; Perini P; Inglese M; Trojano M; Brescia Morra V; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; Schiavetti I; Carmisciano L; et alii...

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Feb;29(2):535-542. doi: 10.1111/ene.15167. Epub 2021 Nov 15.
2022
AOU San Luigi di Orbassano

Tedeschi G; Pisoni E; Brescia Morra V; Trojano M; Inglese M; Perini P; Marfia GA; Confalonieri P; Zito A; Cavalla P; Pesci I; Scandellari C; Cocco E; Brichetto G; De Rossi N; Capobianco M; Immovilli P; Radaelli M; Filippi M; Carmisciano L; Cordioli C; Schiavetti I; Ponzano M; Bergamaschi R; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; et alii...

2022
ASL Cuneo 1
AOU San Luigi di Orbassano

Bellantonio P; Totaro R; Vianello M; Cavalla P; Granella F; Di Sapio A; Bertolotto A; Maimone D; Bergamaschi R; Lus G; Solaro C; Amato MP; Rovaris M; Gasperini C; Ferrò MT; Pesci I; Aguglia U; Maniscalco GT; Sola P; Conte A; De Luca G; Cottone S; Salemi G; Lugaresi A; Inglese M; Bonavita S; Grimaldi LM; Marfia GA; Brescia Morra V; et alii...

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. in Therapeutic advances in neurological disorders / Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollectio
2021
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Caputo F; Paolicelli D; Patti F; Zaffaroni M; Brescia Morra V; Pozzilli C; De Luca G; Inglese M; Salemi G; Maniscalco GT; Cocco E; Sola P; Lus G; Conte A; Amato MP; Granella F; Gasperini C; Bellantonio P; Totaro R; Rovaris M; Salvetti M; Torri Clerici VLA; Bergamaschi R; Maimone D; Scarpini E; Capobianco M; Comi G; et alii...

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2781-2792. doi: 10.1007/s10072-020-04392-8. Epub 2020 Apr 12.
2020
AOU San Luigi di Orbassano

Moccia M; Frau J; Carotenuto A; Butera C; Coghe G; Barbero P; Frontoni M; Groppo E; Giovannelli M; Del Carro U; Inglese C; Frasson E; Castagna A; Buccafusca M; Latino P; Nascimbene C; Romano M; Liotti V; Lanfranchi S; Rapisarda L; Lori S; Esposito M; Maggi L; Petracca M; Lo Fermo S; Altavista MC; Bono F; Eleopra R; Brescia Morra V; et alii...

2019
AOU San Luigi di Orbassano

Paolicelli D; Lucisano G; Manni A; Avolio C; Bonavita S; Brescia Morra V; Capobianco M; Cocco E; Conte A; De Luca G; De Robertis F; Gasperini C; Gatto M; Gazzola P; Lus G; Iaffaldano A; Iaffaldano P; Maimone D; Mallucci G; Maniscalco GT; Marfia GA; Patti F; Pesci I; Pozzilli C; Rovaris M; Salemi G; Salvetti M; Spitaleri D; Totaro R; et alii...

Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10.
2018
AOU San Luigi di Orbassano

Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Pia Sormani M; Ghezzi A;

A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31.
2017
AOU San Luigi di Orbassano

Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Sormani MP; Ghezzi A;

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study). in PloS one / PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.
2017
AOU San Luigi di Orbassano

Messina S; Solaro C; Righini I; Bergamaschi R; Bonavita S; Bossio RB; Brescia Morra V; Costantino G; Cavalla P; Centonze D; Comi G; Cottone S; Danni MC; Francia A; Gajofatto A; Gasperini C; Zaffaroni M; Petrucci L; Signoriello E; Maniscalco GT; Spinicci G; Matta M; Mirabella M; Pedà G; Castelli L; Rovaris M; Sessa E; Spitaleri D; Paolicelli D; et alii...

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):944-51. doi: 10.1136/jnnp-2015-312591. Epub 2016 May 9
2016
AOU San Luigi di Orbassano

Patti F; Messina S; Solaro C; Amato MP; Bergamaschi R; Bonavita S; Bruno Bossio R; Brescia Morra V; Costantino GF; Cavalla P; Centonze D; Comi G; Cottone S; Danni M; Francia A; Gajofatto A; Gasperini C; Ghezzi A; Iudice A; Lus G; Maniscalco GT; Marrosu MG; Matta M; Mirabella M; Montanari E; Pozzilli C; Rovaris M; Sessa E; Spitaleri D; et alii...

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon ?-1a using an electronic device: the RIVER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jul;13(7):931-5. doi: 10.1517/17425247.2016.1148029. Epub 2016 Feb 24.
2016
AOU San Luigi di Orbassano

Lugaresi A; De Robertis F; Clerico M; Brescia Morra V; Centonze D; Borghesan S; Maniscalco GT;

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis. in Brain : a journal of neurology / Brain. 2015 Nov;138(Pt 11):3275-86. doi: 10.1093/brain/awv260. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; et alii...

2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Paolicelli D; Cavalla P; Sola P; Vitetta F; Realmuto S; Salemi G; Bianchi A; Ghezzi A; Lanzillo R; Brescia Morra V; Gned D; Piazza F; De Mercanti SF; Schiavetti I; Clerico M; Trojano M; Sormani MP; Durelli L;